Cure51
France
- Paris
- 20/03/2024
- Seed
- $16,260,975
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
- Industry Biotechnology Research
- Website https://www.cure51.com/
- LinkedIn https://www.linkedin.com/company/cure51/
Related People
Nicolas WolikowFounder
France -
Greater Paris Metropolitan Region
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms.
Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees.
Managing P&L for business divisions exceeding $200M revenue.
Have been Chief Executive Officer, responsible for strategy implementation, business development and acquisitions initiatives. Currently Chief Digital Officer to transform a large organisation. Passionate about product innovations that shape new customer experiences.
catalyx space | $5,400,000 | (Nov 4, 2025)
mimic(SWITZERLAND) | $160,000,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
Zeeg | $1,265,935 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
octonomy | $20,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Hullbot | $16,000,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)